Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects

This study has been completed.
Sponsor:
Collaborators:
Retroscreen Virology Ltd.
Guys Drug Research Unit
Quintiles UK
Information provided by:
Pulmatrix Inc.
ClinicalTrials.gov Identifier:
NCT00947687
First received: July 24, 2009
Last updated: April 27, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)